Condition: Asthma · Sponsor: AstraZeneca
This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Bakersfield, California, United States | Recruiting |
| Research Site | Huntington Beach, California, United States | Withdrawn |
| Research Site | La Mesa, California, United States | Terminated |
| Research Site | Loma Linda, California, United States | Withdrawn |
| Research Site | Long Beach, California, United States | Withdrawn |
| Research Site | Newport Beach, California, United States | Recruiting |
| Research Site | San Jose, California, United States | Recruiting |
| Research Site | Wilmington, Delaware, United States | Terminated |
| Research Site | Cutler Bay, Florida, United States | Suspended |
| Research Site | Hialeah, Florida, United States | Suspended |
| Research Site | Leesburg, Florida, United States | Withdrawn |
| Research Site | Miami, Florida, United States | Suspended |
+ 209 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06932263